neutropenia
Resistance Concerns Cloud Neutropenia Prophylaxis Recs
With concerns of resistance and increased potential for poor outcomes, the benefit of fluoroquinolone prophylaxis ...
FEBRUARY 7, 2023
FDA Approves Stimufend, Biosimilar for Neulasta
The FDA approved Stimufend, a biosimar for Neulasta, for patients with non-myeloid malignancies receiving ...
SEPTEMBER 7, 2022
COVID-19 Precautions Associated With Decline in Neutropenic Fever Among Cancer Patients
Orlando, Fla.—A series of pandemic-related public health measures such as the use of barrier masks, ...
JUNE 2, 2022
FDA Approves Nivestym, Second Biosimilar of Neupogen
The FDA approved Pfizer's Nivestym, a biosimilar of Neupogen for all eligible indications as the reference ...
JULY 23, 2018
Reducing Infection Risk in Young Leukemia Patients
The first few weeks is a crucial stage in monitoring and preventing infection in these children.
SEPTEMBER 14, 2017
Quinolones Reduce Infections, Delay Febrile Neutropenia in Relapsed/Refractory AML Patients
Treating patients with relapsed/refractory AML prophylactically with quinolones reduced the incidence of bacteremia ...
JULY 5, 2016
